BioScrip Closes $70 Million Purchase of HomeChoice Partners

Health care company BioScrip (NASDAQ: BIOS  ) announced today that its acquisition of HomeChoice Partners officially closed on Feb. 1. The $70 million all-cash deal is between BioScrip and DaVita HealthCare Partners (NYSE: DVA  ) , the majority owner of HomeChoice.

HomeChoice is a provider of alternate-site infusion pharmacy services, with 15,000 patients and 14 locations in the east and southeast United States.

"We expect to immediately begin to integrate HomeChoice into our Infusion Services segment to take advantage of increased purchasing power, operating leverage and market synergies," said BioScrip President and CEO Rick Smith in a statement today. "HomeChoice is an important part of our ongoing strategy to build our infusion business through strategic and opportunistic acquisitions, which meet our financial criteria and enable us to expand our national footprint."

BioScrip first announced its intention to acquire HomeChoice on Dec. 12, 2012. HomeChoice is expected to generate approximately $70 million in annual revenue, with EBITDA margins between 12% and 14%. In 2011, Bioscrip pulled in $312 million in sales  with a 2.75% EBITDA margin TTM.  

Bioscrip estimates it will take up to one year for HomeChoice's business to be fully integrated into its own.

link


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2234122, ~/Articles/ArticleHandler.aspx, 10/1/2014 6:45:00 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement